{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:48:45Z","timestamp":1779137325092,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012519","name":"\u00c9cole des Hautes \u00c9tudes en Sant\u00e9 Publique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.canep.2019.03.014","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:40:38Z","timestamp":1554252038000},"page":"106-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: A population-based study"],"prefix":"10.1016","volume":"60","author":[{"given":"N.","family":"Le Stang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Galateau-Sall\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Clin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Sep","key":"10.1016\/j.canep.2019.03.014_bib0005","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.canep.2019.03.014_bib0010","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/crj.12778","article-title":"Global trends in mortality from malignant mesothelioma: analysis of WHO mortality database (1994-2013)","volume":"12","author":"Abdel-Rahman","year":"2018","journal-title":"Clin. Respir. J."},{"issue":"4","key":"10.1016\/j.canep.2019.03.014_bib0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/oemed-2016-104119","article-title":"The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure","volume":"75","author":"Marinaccio","year":"2018","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.canep.2019.03.014_bib0020","series-title":"Pathology of Malignant Mesothelioma; an Update of the International Mesothelioma Panel","author":"Galateau-Sall\u00e9","year":"2006"},{"key":"10.1016\/j.canep.2019.03.014_bib0025","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canep.2019.03.014_bib0030","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: the rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2019.03.014_bib0035","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1245\/s10434-015-4965-6","article-title":"Malignant peritoneal mesothelioma: characterization of the inflammatory response in the tumor microenvironment","volume":"23","author":"Judge","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.canep.2019.03.014_bib0040","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multiinstitutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2019.03.014_bib0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/CEJ.0000000000000372","article-title":"Survival of solid cancer patients in France, 1989-2013: a population-based study","volume":"26","author":"Cowppli-Bony","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.canep.2019.03.014_bib0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ijc.24711","article-title":"Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005","volume":"126","author":"Le Stang","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2019.03.014_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.annpat.2014.01.009","article-title":"The French mesothelioma network from 1998 to 2013","volume":"34","author":"Galateau-Sall\u00e9","year":"2014","journal-title":"Ann. Pathol."},{"issue":"3-4","key":"10.1016\/j.canep.2019.03.014_bib0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1620\/tjem.60.307","article-title":"A proposal on a calculation method to be applied by geographical comparison of cancer mortality","volume":"60","author":"Segi","year":"1954","journal-title":"Tohoku J. Exp. Med."},{"issue":"3-4","key":"10.1016\/j.canep.2019.03.014_bib0065","first-page":"28","article-title":"Programme national de surveillance du m\u00e9soth\u00e9liome (PNSM). Actualisation des principaux r\u00e9sultats","author":"Gilg Soit Ilg","year":"2015","journal-title":"Bull. Epid\u00e9miol. Hebd."},{"key":"10.1016\/j.canep.2019.03.014_bib0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canep.2017.10.008","article-title":"Epidemiology of malignant peritoneal mesothelioma: a population-based study","volume":"51","author":"Salo","year":"2017","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2019.03.014_bib0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canep.2017.10.003","article-title":"Differences between peritoneal and pleural mesothelioma in Lombardy, Italy","volume":"51","author":"Mensi","year":"2017","journal-title":"Cancer Epidemiol."},{"issue":"7","key":"10.1016\/j.canep.2019.03.014_bib0080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ejca.2012.02.047","article-title":"Rare thoracic cancers, including peritoneum mesothelioma","volume":"48","author":"Siesling","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2019.03.014_bib0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ijc.23866","article-title":"Survival of peritoneal malignant mesothelioma in Italy: a population-based study","volume":"124","author":"Mirabelli","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2019.03.014_bib0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: a population-based study","volume":"124","author":"Montanaro","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canep.2019.03.014_bib0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/oemed-2015-103309","article-title":"Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009","volume":"73","author":"Soeberg","year":"2016","journal-title":"Occup. Environ. Med."},{"issue":"6","key":"10.1016\/j.canep.2019.03.014_bib0100","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/annonc\/mdr477","article-title":"Importance of gender in diffuse malignant peritoneal mesothelioma","volume":"23","author":"Cao","year":"2012","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.canep.2019.03.014_bib0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.canep.2019.03.014_bib0110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canep.2019.03.014_bib0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/0008-5472.CAN-15-0751","article-title":"Gender-specific molecular and clinical features underlie malignant pleural mesothelioma","volume":"76","author":"De Rienzo","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canep.2019.03.014_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2016","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.canep.2019.03.014_bib0125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jtho.2016.12.019","article-title":"BAP1 is altered by copy number loss, mutation, and\/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas","volume":"12","author":"Leblay","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2019.03.014_bib0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.canep.2019.03.014_bib0135","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1245\/s10434-018-6631-2","article-title":"Impact of combination chemotherapy in peritoneal mesothelioma hyperthermic intraperitoneal chemotherapy (HIPEC): the RENAPE study","volume":"25","author":"Malgras","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2019.03.014_bib0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13023-017-0571-y","article-title":"The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry","volume":"12","author":"Villeneuve","year":"2017","journal-title":"Orphan. J. Rare Dis."},{"issue":"1","key":"10.1016\/j.canep.2019.03.014_bib0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.annpat.2014.01.008","article-title":"The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists","volume":"34","author":"Villeneuve","year":"2014","journal-title":"Ann. Pathol."},{"key":"10.1016\/j.canep.2019.03.014_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","article-title":"Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: multi-Institutional Retrospective Study","volume":"65","author":"Kepenekian","year":"2016","journal-title":"Eur. J. Cancer"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118306465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118306465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:26:28Z","timestamp":1761801988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782118306465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":30,"alternative-id":["S1877782118306465"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2019.03.014","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2019.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}